Antivenom Market study: Burden of Snakebite and its Situation Analysis in ASEAN countries

Snakebite is a public health problem with substantial morbidity and mortality that affects an estimated 5.4 million people annually. The Association of South East Asia Nations (ASEAN) is recognised as having one of the highest regional burdens of snakebite, however, the true magnitude, especially the economic aspects remain unknown. The result is a lack of access to effective antivenom due to inadequate understanding of demand and supply in the antivenom market. This study will collect the Clinical and Antivenom Market data to provide a more accurate assessment of the burden of snakebite and project the clinical and economic implications of scenarios with various levels of antivenom availability in 7 ASEAN. This is a critical first step in the development of national and regional action plans to address the burden of snakebite.